Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 752 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Deflazacort, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Deflazacort, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Polymyxin b sulfate
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Daptomycin 350 mg/7mL; Lithium carbonate 300 mg/1; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 100 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 2 g/1; Cefepime hydrochloride 1 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Neomycin sulfate 3.5 mg/mL; Polymyxin b sulfate 10000 [iU]/mL; Hydrocortisone 10 mg/mL; Deflazacort 36 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Tablet, Film coated, Extended release, Capsule, Capsule, Gelatin coated, Solution, Suspension, Solution/ drops, Liquid, Injection, Suspension
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Auricular (Otic), Intravascular, Intrathecal, Ophthalmic, Intra-articular
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Corticosteroid, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Polymyxin-class Antibacterial, Penem Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Aminoglycoside Antibacterial, Cholinergic Receptor Agonist, Benzodiazepine, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Central alpha-2 Adrenergic Agonist, Prostaglandin Analog, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 110 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Sterile Water | Water 1 mL/mL | Injection, SolutionIntravenous | 0143-9339 | 00143-9339-12 | — |
| Dobutamine | Dobutamine hydrochloride 12.5 mg/mL | Injection, SolutionIntravenous | 0143-9141 | 00143-9141-10 | — |
| Medroxyprogesterone Acetate Injectable Suspensionmedroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 24201-150 | 24201-0150-0124201-0150-25 | J1050 |
| Regadenoson | Regadenoson anhydrous .08 mg/mL | Injection, SolutionIntravenous | 0641-6253 | 00641-6253-01 | — |
| Dihydroergotamine Mesylate | Dihydroergotamine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0143-9151 | 00143-9151-10 | — |
| posaconazole | Posaconazole 40 mg/mL | SuspensionOral | 0054-0449 | 00054-0449-49 | — |
| Immphentivphenylephrine hydrochloride | Phenylephrine hydrochloride 100 ug/mL | InjectionIntravenous | 0641-6245 | 00641-6245-10 | — |
| Immphentivphenylephrine hydrochloride | Phenylephrine hydrochloride 100 ug/mL | Injectable, LiposomalIntravenous | 0641-6246 | 00641-6246-10 | — |
| Acetaminophen | Acetaminophen 10 mg/mL | Injection, SolutionIntravenous | 24201-100 | 24201-0100-24 | J0131 |
| Acetaminophen | Acetaminophen 10 mg/mL | Injection, SolutionIntravenous | 24201-110 | 24201-0110-24 | J0131 |
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntravenous | 0143-9139 | 00143-9139-25 | — |
| Cefazolin | Cefazolin sodium 3 g/1 | Injection, Powder, For solutionIntravenous | 0143-9140 | 00143-9140-25 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 5.13 g/g | Injection, Powder, For solutionIntravenous, Oral | 0143-9163 | 00143-9163-01 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 513 mg/mg | Injection, Powder, For solutionIntravenous, Oral | 0143-9161 | 00143-9161-1000143-9161-25 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 1025 mg/mg | Injection, Powder, For solutionIntravenous, Oral | 0143-9162 | 00143-9162-10 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10.25 g/g | Injection, Powder, For solutionIntravenous, Oral | 0143-9164 | 00143-9164-01 | — |
| Fentanyl Citrate | Fentanyl citrate 50 ug/mL | InjectionIntramuscular, Intravenous | 0641-6248 | 00641-6248-10 | — |
| sodium oxybate | Sodium oxybate .5 g/mL | SolutionOral | 0054-9628 | 00054-9628-57 | — |
| Linezolid | Linezolid 600 mg/300mL | Injection, SolutionIntravenous | 0143-9534 | 00143-9534-10 | — |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/mL | Injection, SolutionIntravenous | 24201-002 | 24201-0002-01 | — |
| Mitomycin | Mitomycin 20 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9135 | 00143-9135-01 | — |
| Mitomycin | Mitomycin 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9136 | 00143-9136-01 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 40 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9753 | 00143-9753-25 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9754 | 00143-9754-25 | — |
| Vigabatrin | Vigabatrin 500 mg/1 | TabletOral | 0054-0652 | 00054-0652-25 | — |
| bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 0143-9098 | 00143-9098-01 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6205 | 00641-6205-10 | — |
| Acetaminophen | Acetaminophen 1000 mg/100mL | InjectionIntravenous | 0143-9386 | 00143-9386-10 | J0131 |
| Droperidol | Droperidol 2.5 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0143-9514 | 00143-9514-25 | — |
| Droperidol | Droperidol 2.5 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0143-9515 | 00143-9515-25 | — |
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Butalbital 50 mg/1 + 3 more ingredients | CapsuleOral | 0054-3000 | 00054-3000-01 | — |
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Butalbital 50 mg/1 + 3 more ingredients | CapsuleOral | 0054-0650 | 00054-0650-25 | — |
| decitabine | Decitabine 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9385 | 00143-9385-01 | — |
| Naloxone Hydrochloridenalxone hydrochloride | Naloxone hydrochloride .4 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6260 | 00641-6260-25 | — |
| Gentamicin | Gentamicin sulfate 40 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0143-9128 | 00143-9128-25 | — |
| Gentamicin | Gentamicin sulfate 40 mg/mL | Injection, SolutionIntramuscular, Intravenous | 0143-9129 | 00143-9129-10 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | InjectionIntramuscular | 0143-9022 | 00143-9022-02 | — |
| Deferiprone | Deferiprone 1000 mg/1 | Tablet, CoatedOral | 0054-0711 | 00054-0711-1900054-0711-2300054-0711-28 | — |
| Atropine Sulfate | Atropine sulfate .4 mg/mL | InjectionEndotracheal, Intramedullary, Intramuscular, Intravenous, Subcutaneous | 0641-6251 | 00641-6251-10 | — |
| Albuterol Sulfate | Albuterol sulfate 90 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 0054-0742 | 00054-0742-87 | — |
| Testosterone Cypionate | Testosterone cypionate 200 mg/mL | InjectionIntramuscular | 0143-9005 | 00143-9005-01 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | 0054-0604 | 00054-0604-21 | — |
| Benztropine Mesylate | Benztropine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous | 0143-9233 | 00143-9233-05 | — |
| ertapenem sodium | Ertapenem sodium 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 0143-9398 | 00143-9398-10 | — |
| Micafunginmicafungin sodium | Micafungin 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9361 | 00143-9361-01 | — |
| Micafunginmicafungin sodium | Micafungin 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9362 | 00143-9362-01 | — |
| Ganciclovirganciclovir sodium | Ganciclovir sodium 50 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9299 | 00143-9299-10 | — |
| Deferiprone | Deferiprone 500 mg/1 | Tablet, CoatedOral | 0054-0576 | 00054-0576-25 | — |
| Rufinamide | Rufinamide 400 mg/1 | Tablet, Film coatedOral | 0054-0426 | 00054-0426-23 | — |
| Rufinamide | Rufinamide 200 mg/1 | Tablet, Film coatedOral | 0054-0425 | 00054-0425-23 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.